MSD Animal Health Introduces NOBIVAC Myxo-RHD
MSD Animal Health Ireland introduced NOBIVAC Myxo-RHD PLUS vaccine to reduce mortality and clinical signs of the three most common viral diseases in rabbits: myxomatosis and rabbit haemorrhagic disease (RHD) caused by both classic (RHDV1) and variant (RHDV2) strains.
Rabbits have become increasingly popular as a companion animal and are now the fourth most popular pet in Europe , after dogs, cats and birds.
“MSD Animal Health is proud to introduce NOBIVAC Myxo-RHD PLUS, the first and only single injection vaccine to protect pet rabbits against the three most common and often fatal viral diseases affecting them, as part of our ongoing commitment to innovation that improves the health and welfare of animals,’ said Jessie Collins, marketing associate, MSD Animal Health.
The single injection vaccine is indicated for the active immunization of rabbits, and provides onset of immunity in three weeks, with a duration of immunity of one year against all three diseases*. Available on prescription from veterinary practitioners, the product is presented in a pack of five single doses for subcutaneous administration.